{"entity":{"type":"insider","cik":"0001410598","url":"/insider/0001410598","json_url":"/insider/0001410598.json","name":"WEIS ALEXANDER L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":3,"first":"2011-01-11","last":"2011-07-05","span_basis":"filed_date"},"name_variants":[{"name":"WEIS ALEXANDER L","source":"filing","n_filings":3,"first_seen":"2011-01-11","last_seen":"2011-07-05"}],"transactions":[{"id":8999825,"accession":"0001410598-11-000004","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001410598-11-000004","line_url":"/filing/0001410598-11-000004","is_derivative":false,"issuer_cik":"0001094847","issuer_name":"ONCOVISTA INNOVATIVE THERAPIES, INC","issuer_ticker":"OVIT","issuer_name_source":null,"issuer_url":"/issuer/0001094847","owner_cik":"0001410598","owner_name":"WEIS ALEXANDER L","owner_display_name":"WEIS ALEXANDER L","owner_url":"/insider/0001410598","role":"Director, Officer (President, CEO, CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, CFO, Secretary","security_title":"Shares of Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":0.6186363636363637,"price_display":"0.62","price_state":"stated","total_value":13610.0,"total_display":"13,610.00","total_whole":"13,610","shares_owned_after":5354200.0,"shares_owned_after_display":"5,354,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-30","filed_date":"2011-07-05","scope":"insider","n_lines":4},{"id":8999821,"accession":"0001410598-11-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001410598-11-000004","line_url":"/filing/0001410598-11-000004#line-4","is_derivative":false,"issuer_cik":"0001094847","issuer_name":"ONCOVISTA INNOVATIVE THERAPIES, INC","issuer_ticker":"OVIT","issuer_name_source":null,"issuer_url":"/issuer/0001094847","owner_cik":"0001410598","owner_name":"WEIS ALEXANDER L","owner_display_name":"WEIS ALEXANDER L","owner_url":"/insider/0001410598","role":"Director, Officer (President, CEO, CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, CFO, Secretary","security_title":"Shares of Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":110.0,"total_display":"110.00","total_whole":"110","shares_owned_after":5334200.0,"shares_owned_after_display":"5,334,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-29","filed_date":"2011-07-05","scope":"insider"},{"id":8999820,"accession":"0001410598-11-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001410598-11-000004","line_url":"/filing/0001410598-11-000004","is_derivative":false,"issuer_cik":"0001094847","issuer_name":"ONCOVISTA INNOVATIVE THERAPIES, INC","issuer_ticker":"OVIT","issuer_name_source":null,"issuer_url":"/issuer/0001094847","owner_cik":"0001410598","owner_name":"WEIS ALEXANDER L","owner_display_name":"WEIS ALEXANDER L","owner_url":"/insider/0001410598","role":"Director, Officer (President, CEO, CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, CFO, Secretary","security_title":"Shares of Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.576,"price_display":"0.58","price_state":"stated","total_value":8640.0,"total_display":"8,640.00","total_whole":"8,640","shares_owned_after":5334000.0,"shares_owned_after_display":"5,334,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-28","filed_date":"2011-07-05","scope":"insider","n_lines":3},{"id":8980180,"accession":"0001410598-11-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001410598-11-000003","line_url":"/filing/0001410598-11-000003","is_derivative":false,"issuer_cik":"0001094847","issuer_name":"ONCOVISTA INNOVATIVE THERAPIES, INC","issuer_ticker":"OVIT","issuer_name_source":null,"issuer_url":"/issuer/0001094847","owner_cik":"0001410598","owner_name":"WEIS ALEXANDER L","owner_display_name":"WEIS ALEXANDER L","owner_url":"/insider/0001410598","role":"Director, Officer (President, CEO, CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, CFO, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34000.0,"shares_display":"34,000","price_per_share":0.44279411764705884,"price_display":"0.44","price_state":"stated","total_value":15055.0,"total_display":"15,055.00","total_whole":"15,055","shares_owned_after":5304500.0,"shares_owned_after_display":"5,304,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-08","filed_date":"2011-03-10","scope":"insider","n_lines":3},{"id":9145440,"accession":"0001410598-11-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001410598-11-000002","line_url":"/filing/0001410598-11-000002","is_derivative":false,"issuer_cik":"0001094847","issuer_name":"ONCOVISTA INNOVATIVE THERAPIES, INC","issuer_ticker":"OVIT","issuer_name_source":null,"issuer_url":"/issuer/0001094847","owner_cik":"0001410598","owner_name":"WEIS ALEXANDER L","owner_display_name":"WEIS ALEXANDER L","owner_url":"/insider/0001410598","role":"Director, Officer (President, CEO, CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, CFO, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":0.30466666666666664,"price_display":"0.30","price_state":"stated","total_value":22850.0,"total_display":"22,850.00","total_whole":"22,850","shares_owned_after":5285000.0,"shares_owned_after_display":"5,285,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-03","filed_date":"2011-01-11","scope":"insider","n_lines":2},{"id":9145438,"accession":"0001410598-11-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001410598-11-000002","line_url":"/filing/0001410598-11-000002","is_derivative":false,"issuer_cik":"0001094847","issuer_name":"ONCOVISTA INNOVATIVE THERAPIES, INC","issuer_ticker":"OVIT","issuer_name_source":null,"issuer_url":"/issuer/0001094847","owner_cik":"0001410598","owner_name":"WEIS ALEXANDER L","owner_display_name":"WEIS ALEXANDER L","owner_url":"/insider/0001410598","role":"Director, Officer (President, CEO, CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, CFO, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.307,"price_display":"0.31","price_state":"stated","total_value":15350.0,"total_display":"15,350.00","total_whole":"15,350","shares_owned_after":5200000.0,"shares_owned_after_display":"5,200,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-29","filed_date":"2011-01-11","scope":"insider","n_lines":2},{"id":9145436,"accession":"0001410598-11-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001410598-11-000002","line_url":"/filing/0001410598-11-000002#line-1","is_derivative":false,"issuer_cik":"0001094847","issuer_name":"ONCOVISTA INNOVATIVE THERAPIES, INC","issuer_ticker":"OVIT","issuer_name_source":null,"issuer_url":"/issuer/0001094847","owner_cik":"0001410598","owner_name":"WEIS ALEXANDER L","owner_display_name":"WEIS ALEXANDER L","owner_url":"/insider/0001410598","role":"Director, Officer (President, CEO, CFO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, CFO, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":3300.0,"total_display":"3,300.00","total_whole":"3,300","shares_owned_after":5210000.0,"shares_owned_after_display":"5,210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-20","filed_date":"2011-01-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001094847","name":"ONCOVISTA INNOVATIVE THERAPIES, INC","url":"/issuer/0001094847","role":"Director, Officer (President, CEO, CFO, Secretary), Ten percent owner","n_filings":3,"first_seen":"2011-01-11","last_seen":"2011-07-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001410598","retrieved_at":"2026-08-26T21:28:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}